AMF Tjanstepension AB Purchases 71,585 Shares of UnitedHealth Group Incorporated $UNH

AMF Tjanstepension AB boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 30.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 309,549 shares of the healthcare conglomerate’s stock after acquiring an additional 71,585 shares during the quarter. AMF Tjanstepension AB’s holdings in UnitedHealth Group were worth $96,629,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Nuveen LLC acquired a new stake in UnitedHealth Group in the first quarter valued at approximately $3,846,764,000. Vanguard Group Inc. boosted its position in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP boosted its position in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after buying an additional 2,486,839 shares in the last quarter. National Bank of Canada FI boosted its position in UnitedHealth Group by 137.8% in the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after buying an additional 950,928 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after purchasing an additional 847,054 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.8%

UNH opened at $360.17 on Friday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market cap of $326.20 billion, a P/E ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47. The company has a fifty day moving average price of $307.84 and a two-hundred day moving average price of $355.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the firm posted $6.80 earnings per share. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is presently 38.30%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent research reports. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Barclays lifted their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. KeyCorp cut their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Cantor Fitzgerald reiterated an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, JPMorgan Chase & Co. dropped their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a report on Wednesday, August 6th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Hold” and an average target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.